Clinical

Dataset Information

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer


ABSTRACT: The main purpose of this study is to evaluate the safety of the study drug prexasertib in combination with ralimetinib in participants with advanced or metastatic cancer.

DISEASE(S): Neoplasm Metastasis,Neoplasms, Second Primary,Colorectal Cancer,Non-small Cell Lung Cancer,Advanced Cancer,Metastatic Cancer,Neoplasms

PROVIDER: 2221933 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR